In our previous report, we demonstrated the beneficial impact of Exendin-4, GLP-1 analog, on DPN in diabetic mice [51], complementing the existing literature that has shown that DPP-4 inhibitors mitigate the progression of DPN in rodent models of diabetes [42,43,44,45]. The gene discussed is GCG; the disease is diabetes mellitus.